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A study was undertaken to evaluate the effects of polysaccharide from Lycium barbarum (LBP) in 
alloxan-induced diabetic mice. The various parameters studied included body weight, fasting blood 
glucose levels, total cholesterol (TC) and triglyceride (TG) in diabetic and normal mice. LBP treatment 
(20, 40 mg/ kg body weight) for 28 days resulted in a significant decrease in the concentration of fasting 
blood glucose (FBG), total cholesterol (TC) and triglyceride (TG) in diabetes mellitus mice. Furthermore, 
LBP significantly increased body weight (bw). The data demonstrated LBP at the dose of 40 mg/kg bw 
exhibited the optimal effect.  
 





Diabetes mellitus is found in all parts of the world and is 
rapidly increasing in most parts of the world. As a devas-
tating disease, diabetes is affecting approximately 3% of 
the population worldwide (Skyler, 2004). For a long time, 
diabetics have been treated with several medicinal plants 
or their extracts based on the folklore medicine (Akhtar 
and Ali, 1984). Synthetic hypoglycemic agents can 
produce serious side effects and in addition, they are not 
suitable for use during pregnancy (Pari and Saravanan, 
2002). Therefore, the search for more effective and safer 
hypoglycemic agents has continued to be an important 
area of active research.  
Lycium barbarum species are deciduous woody peren-
nial plants, produce a bright orange-red, ellipsoid berry 1 
- 2 cm long. The berries have been used in traditional 
Chinese medicine for about 1,900 years (Jin et al., 2006). 
They have been used for the treatment of cerebral 
arteriosclerosis, liver or heart diseases, hypercholeste-
rolemia and diabetes (Zhao and Liu, 2008). The active 
components of L. barbarum primarily contain water-
soluble polysaccharides (Chen and Mu, 2007). They 
could be extracted with hot water followed by precipitation 
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(Zhi et al., 2004; Gan et al., 2004; Zhang et al., 2004). 
LBP have been recently studied for their physiological 
and pharmaceutical activities. The purpose of this study 








Dried L. barbarum was purchased from a local drug market and the 
material was identified by Mr. King Li, a botanist of Qujing Normal 
University. A voucher specimen has been deposited in herbarium of 
Qujing Normal University. 
 
 
Drugs and reagents 
 
Alloxan was purchased from Sigma Co. (USA). Glucose Analyzer 
and strips were purchased from Roche Diagnostic Co. (USA). 
Reagents for total cholesterol (TC) and triglyceride (TG) were 
obtained from Beijing Chengxinde Biochemistry Reagent Company 
(Beijing, China). Reagents for serum insulin were purchased from 
Adlitteram Diagnostic Laboratories Co. (USA). 
 
 
Extraction of LBP 
 
Dried L. barbarum was crushed in an electrical grinder and then 





boiled at 100°C for 12 h (Ayiguli et al., 2007; Luo et al., 2000) and 
then the water extract was collected. The process was repeated 
once and the extracts were combined and concentrated with a 
vacuum rotary evaporator at 70°C. The concentrated solution was 
precipitated with addition of 4 times volume 95% ethanol and the 
precipitation was washed in turn with 100% ethanol, 100% ether 
and acetone; polysaccharide from L. barbarum was obtained by 
vacuum drying (Luo et al., 2000). The Unico-7200 spectrophoto-
meter (Unico Co., Shanghai, China) was used to determine the 
content of polysaccharides in the above extracted product at 490 
nm (Ayiguli et al., 2007; Wang et al., 2007). 
 
 
Experimental animals    
 
Male mice of original Kun-ming strain (18 - 22 g each) were used 
for the study. The study was carried out according to the “Principles 
of Laboratory Animal Care” (World Health Organization (WHO) 
Chronicle, 1985). A standard pellet diet and water were given ad 
libitum. Animals were maintained under a constant 12-h light and 
dark cycle and an environmental temperatures of 21 – 23oC. 
 
 
Preparation of alloxan-induced diabetic mice 
 
Diabetes was induced in fasted mice (12 h) by intraperitoneal inject-
tion of 200 mg/kg bw of alloxan, freshly dissolved in sterile normal 
saline immediately before at a concentration of 40 g/L. Diabetes 
was confirmed by the determination of tail vein blood glucose levels 
on the third day after administration of alloxan. The mice with a 
blood glucose level above 11 mmol/L, as well as with polydipsia, 
polyuria and polyphagia were selected for the experiment (Zhang et 
al., 2004; Yang et al., 2006). 
 
 
Experimental design  
 
Forty Male mice were randomly divided into five equal groups as 
follows: 
 
i) Normal control group (NC): normal control mice administered 
water daily for 28 days; 
ii) Diabetic control group (DC): diabetic control mice administered 
water daily for 28 days;  
iii) Diabetic + LBP (20 mg/kg) group (DLL): diabetic mice 
administered LBP (20 mg/kg) daily for 28 days; 
iv) Diabetic + LBP (40 mg/kg) group (DLH): diabetic mice 
administered LBP (40 mg/kg) daily for 28 days;  
v) Diabetic + glibenclamide (4 mg/kg) group (DG): diabetic mice 
administered reference drug glibenclamide (4 mg/kg) daily for 28 
days.  
 
Animals of control group, NC and DC groups were subjected to 
forceful feeding of 0.5 mL distilled water/100 g bw daily for 28 days 
to keep all the animals at same type of treatment condition in 
respect to BLP supplemented groups.  
During LBP and Glib supplement for 28 days, fasting blood 
glucose level was measured for once every week. Blood was 
collected from tip of the tail vein and fasting blood glucose level was 
measured by using a glucose analyzer. At the same time, the body 
weight of each mouse was measured by balance. On 28th day of 
experiment, the mice were sacrificed by decapitation under light 
ether anesthesia and blood was collected from dorsal aorta and 
serum was separated by centrifugation for 5 min and was kept at -
20°C for the biochemical assay of total cholesterol (TC) and trigly-
ceride (TG). TC and TG were determined by enzyme methods.  




Acute toxicity studies 
 
LBP was tested for its acute toxicity in male mice. The test was 
carried out by single oral administration of LBP at doses of 80, 240, 
400 mg/kg to different groups of mice (5 mice in each group). The 
mortality and general behavior was observed continuously for 1, 4 h 
and intermittently for next 6 h and again at 24 and 48 h. The 
parameters observed are gross behavioral changes, grooming, 
alertness, sedation, loss of righting reflex, tremors convulsions 





All results were expressed as means ± SEM for each group (N = 8). 
Data were analysed statistically by one-way analysis of variance 
(ANOVA). The significance of the difference between the means of 
test and control studies was established by student’s t-test. P 





Acute toxicity studies  
 
In the present study, toxicity test was carried up to high 
concentration of 400 mg/kg (10 times more than chosen 
dose). Even at this dose extract did not exhibit any sign 
of toxicity. Since the main purpose of this test is to get 
some idea on conspicuous behavioral changes and 
death, if any and the LBP did not exhibit any toxic symp-
toms in the limited toxicity evaluation in male mice. 
 
 
Effect of LBP on body weight  
 
The alloxan-induced diabetic mice exhibited loss of body 
weight. Before embarking on the experiment, all the 
groups had no significant difference in body weight (P > 
0.05). A significant (P < 0.05) decrease in body weight 
was detected in the DC, DLL and DLH groups as com-
pared to the normal control group from 7 days after 
alloxan injection. However, the body weights in the DLH 
groups were significantly (P < 0.05) and dose-depen-
dently increased as compared to those of the diabetic 
control from 14 days after administration, which is com-
parable to that of the DG group. The results were shown 
in Figure 1. 
 
 
Effect of LBP on fasting blood glucose levels  
 
The alloxan-induced diabetic mice exhibited hypergly-
cemia. At the beginning, a significant (P < 0.05) increase 
in FBG was detected in the diabetic groups as compared 
to the normal control group. But these abnormal 
increases in blood glucose levels significantly (P < 0.05) 
and dose-dependently decreased in the LBP –admini-
stered groups as compared to the diabetic control group 
from 7 days after administration. In the DG group, de-
crease was also significant  (P < 0.05)  from  7 days  after  






























Table 1. Effect of LBP on blood glucose level (mmol/L) in mice. 
 
Groups Days after dosing (day) 
0 7 14 21 28 
NC 5.03±0.14 5.02±0.16 4.98±0.17 4.92±0.08 5.04±0.11 
DC 15.24±0.39x 15.21±0.26x 15.21±0.35x 15.03±0.15x 15.12±0.29x 
DLL 15.13±0.30x 9.43±0.21xy 8.41±0.21xy 7.45±0.15xy 6.79±0.16xy 
DLH 15.28±0.28x 8.62±0.11xy 7.61±0.28xy 6.12±0.17xy 5.23±0.16xy 
DG 15.17±0.29x 8.96±0.12xy 7.12±0.23xy 6.35±0.24xy 5.56±0.34xy 
 
N = 8; (mean ± S.D., g); x(P < 0.05) as compared with normal control group; y(P < 0.05) as 




administration. NC and DC groups did not show any 
significant variation on the blood glucose level throughout 
the experimental period (p > 0.05). The results were 
shown in Table 1. 
 
 
Effect of LBP on blood lipids levels 
 
Diabetes mellitus is usually complicated with hyperlipo-
proteinemia. The present results showed that the TC and 
TG levels were significantly elevated in the diabetic 
control group as compared to the normal control group (P 
< 0.05). After supplementation with LBP, the alteration in 
lipid metabolism was partially attenuated as evidenced by 
decreased serum TG and TC levels in diabetic mice. The 
response was better in DLH group compared to the 





Diabetes mellitus is a serious chronic disease. Although 
oral anti-hyperglycemic agents and insulin are often 
successful in diabetes treatment, they have prominent 
side effects and fail to significantly alter the course of 
diabetic complications. Effective control of the blood glu-
cose level is a key step in preventing or reversing 
diabetic complications and improving the quality of life in 
both type 1 and type 2 diabetic patients (Chen et al., 
2008). The present study shows that alloxan-induced 
diabetic mice presented obvious hyperglycemic symp-
toms, but LBP produces a significant antihyperglycemic 
effect when oral administration to alloxan-diabetic mice. 
The dosage of 40 mg/kg is more effective than that of 20 
mg/kg. 
The levels of serum lipids are usually elevated in dia-
betes mellitus (Pushparaj et al., 2000). This abnormal 
high level of serum lipids is mainly due to the uninhibited 
actions of lipolytic hormones on the fat depots. Under 
normal circumstances, insulin activates the enzyme lipo-
protein lipase, which hydrolyses triglycerides (Taskinen, 
1987). However, in diabetic state lipoprotein lipase is not 
activated due to insulin deficiency and this results in 





Table 2. Effect of LBP on blood lipids (mmol/L ) in mice. 
 
Groups TG TC 
NC 1.58±0.03 2.64±0.04 
DC 1.99±0.03x 3.28±0.05x 
DLL 1.71±0.03xy 3.03±0.08xy 
DLH 1.64±0.03xy 2.75±0.11xy 
DG 1.66±0.0xy 2097±0.05xy 
 
N = 8; (mean ± S.D., g); x(P < 0.05) as compared with 





the LBP on diabetic hypercholesterolemia and hyper-
triglyceridemia could be through its control of hypergly-
cemia. In this study, the serum TC and TG have been 
decreased significantly in diabetic mice after LBP supple-
mentation. These effects may be due to low activity of 
cholesterol biosynthesis enzymes and or low level of 
lipolysis which are under the control of insulin (Sharma et 
al., 2003). 
L. barbarum has been used to treat diabetes in folk 
tradition for a long time. From this study, we could con-
clude LBP possesses hypoglycemic effects and the dose 
of 40 mg/kg bw represents the optimal level for effecting 
a positive diabetic response in mice. Toxicity data have 
already proved that the LBP did not show any toxic 
reactions in the limited toxicity evaluation in male mice. 
So, it can be said that L. barbarum is a good natural 
material to develop new agent to treat diabetes. It can 
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